AVITA Medical (AVHHL) Long-Term Investments (2021 - 2023)

AVITA Medical has reported Long-Term Investments for 3 years, with the latest figure at $2.8 million in Q2 2023.

• For the quarter ending Q2 2023, Long-Term Investments fell 59.16% year-over-year to $2.8 million; the trailing twelve-month figure through Jun 2023 stood at $2.8 million (down 59.16% YoY), and the FY2022 full-year result was $6.9 million, down 64.81% from the prior year.
• Long-Term Investments for Q2 2023 stood at $2.8 million, down from $4.2 million in the prior quarter.
• The five-year high for Long-Term Investments was $19.8 million in Q3 2021, with the low at $2.8 million in Q2 2023.
• Historically, Long-Term Investments has averaged $9.5 million across 3 years, with a median of $6.8 million in 2022.
• Annual changes were most pronounced in 2022 — Long-Term Investments plunged 79.74% — and 2023, when it tumbled 59.16%.
• AVITA Medical's Long-Term Investments stood at $19.7 million in 2021, then tumbled by 64.81% to $6.9 million in 2022, then sank by 60.26% to $2.8 million in 2023.
• The last three Long-Term Investments figures came in at $2.8 million (Q2 2023), $4.2 million (Q1 2023), and $6.9 million (Q4 2022), per Business Quant data.